Competency information
Details
Measure the radiochemical purity of a prepared radiopharmaceutical such as technetium-99m-labelled methylene diphosphonate (MDP) using a miniaturised two-system thin-layer chromatography (TLC) assay
- Calculate percentage purity and see if it meets the required specification
- Repeat the assay towards the end of the shelf life of the material
- Complete the documentation to record these activities
Considerations
- Radiopharmaceuticals in routine clinical practice together with any particular problems arising from their use.
- Activities normally undertaken in a hospital radiopharmacy.
- Radiopharmaceuticals preparation.
- Quality assurance in radiopharmacy in particular and describe the most important means of control of aseptic preparation and how the principles of quality assurance are routinely applied in a radiopharmaceutical production system.
- Nomenclature, principles, and mechanisms of atomic reactions.
- The design and principles of particle accelerators and nuclear reactors and their relevance for production of radionuclides used in nuclear medicine.
- Qualitative and quantitative terms the interactions of radiation with biological systems.
- Relative risks of nuclear medicine procedures compared with other potentially hazardous life events.
- The principles of the most important types of radiation detectors used in nuclear medicine together with the way in which they are normally employed.
- The structure of the atom, the most important means of radioactive decay of unstable nuclei and the types of radiation emitted there from.
- Radionuclides used in nuclear medicine:
- the relationships between their physical properties, their clinical applications, and their strengths and weaknesses
- the radiopharmaceutical chemistry of these radionuclides
- the influence of these chemical properties on the biodistribution of their radiopharmaceuticals
- the different formulations used in nuclear medicine; properties and preparation
- radiopharmaceutical kits and reagents used therein.
- Technetium-99m generators.
- Methods of measuring molybdenum breakthrough and radiochemical purity.
Relevant learning outcomes
# | Outcome |
---|---|
# 7 | Outcome Measure the radiochemical purity of a prepared radiopharmaceutical such as technetium-99m labelled methylene diphosphonate (MDP) using a miniaturised two-system thin-layer chromatography (TLC) assay. |
# 6 | Outcome Complete the documentation that would normally be used to record these activities in the radiopharmacy. |